FMR LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 315066 BOSTON, MA

Back to CRNX Full portfolio

Position in CRNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$572,395,898

-$92,979,326 QoQ

Shares Held

15,759,799

+10.3% QoQ

Ownership

14.9%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.99414332632034.ToString("F0")% Shared 0.ToString("F0")% None 0.00585667367965797.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,683,576,696 across 351 Biotechnology names. CRNX ranks #25 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

All Filings in CRNX

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$572,395,898	15,759,799	+10.3%	Shares	Defined	2026-05-15
2025-12-31	$665,375,224	14,293,775	+0.7%	Shares	Defined	2026-02-17
2025-09-30	$590,909,289	14,187,498	+0.4%	Shares	Defined	2025-11-13
2025-06-30	$406,263,728	14,125,999	+0.7%	Shares	Defined	2025-08-14
2025-03-31	$470,608,761	14,031,269	+45.7%	Shares	Defined	2025-05-12
2025-01-31	$388,154,971	9,631,637	+7.9%	Shares	Sole	2025-02-07
2024-12-31	$456,493,035	8,928,086	+100.4%	Shares	Defined	2025-02-13
2024-09-30	$227,689,846	4,455,770	+8.8%	Shares	Defined	2024-11-13
2024-06-30	$183,495,446	4,096,795	-8.2%	Shares	Defined	2024-08-13
2024-03-31	$208,944,671	4,463,676	+10.4%	Shares	Defined	2024-05-13
2023-12-31	$143,880,715	4,043,865	+88.9%	Shares	Defined	2024-02-13
2023-09-30	$63,669,205	2,140,861	+97.7%	Shares	Defined	2023-11-13
2023-06-30	$19,514,110	1,082,914	+17.6%	Shares	Defined	2023-08-11
2023-03-31	$14,790,584	920,958	-51.1%	Shares	Defined	2023-08-11
2022-12-31	$34,461,059	1,883,118	-29.8%	Shares	Defined	2023-02-13
2022-09-30	$52,666,682	2,681,603	-10.2%	Shares	Defined	2022-11-10
2022-06-30	$55,707,922	2,987,020	-10.5%	Shares	Defined	2022-08-12
2022-03-31	$73,255,819	3,337,395	-10.3%	Shares	Defined	2022-05-13
2021-12-31	$105,750,399	3,722,295	-15.9%	Shares	Defined	2022-02-14
2021-09-30	$93,176,434	4,426,434	-13.5%	Shares	Defined	2022-02-14
2021-06-30	$96,492,169	5,118,948	+3.7%	Shares	Defined	2021-08-13
2021-03-31	$75,457,468	4,938,316	-0.0%	Shares	Defined	2021-05-14
2020-12-31	$69,680,103	4,938,349	+0.1%	Shares	Defined	2021-02-08
2020-09-30	$77,292,524	4,932,516	+0.1%	Shares	Defined	2020-11-13
2020-06-30	$86,318,148	4,926,835	+43.3%	Shares	Defined	2020-08-24
2020-03-31	$50,543,009	3,438,300	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.